218 related articles for article (PubMed ID: 28992884)
1. Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis.
Kim NH; Kim HJ; Bang KB
Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):512-518. PubMed ID: 28992884
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography.
Brand M; Bizos D; O'Farrell P
Cochrane Database Syst Rev; 2010 Oct; (10):CD007345. PubMed ID: 20927758
[TBL] [Abstract][Full Text] [Related]
3. [ERCP under ceftriaxone antibiotic cover in patients with obstructive jaundice].
Werth B; Stalder GA; Marbet U; Gyr K
Schweiz Rundsch Med Prax; 1990 Mar; 79(13):387-8. PubMed ID: 2320812
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial.
van den Hazel SJ; Speelman P; Dankert J; Huibregtse K; Tytgat GN; van Leeuwen DJ
Ann Intern Med; 1996 Sep; 125(6):442-7. PubMed ID: 8779455
[TBL] [Abstract][Full Text] [Related]
5. Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.
Lee HS; Chung MJ; Park JY; Bang S; Park SW; Song SY; Chung JB
PLoS One; 2018; 13(2):e0190835. PubMed ID: 29401491
[TBL] [Abstract][Full Text] [Related]
6. Post-ERCP pancreatitis: reduction by routine antibiotics.
Räty S; Sand J; Pulkkinen M; Matikainen M; Nordback I
J Gastrointest Surg; 2001; 5(4):339-45; discussion 345. PubMed ID: 11985972
[TBL] [Abstract][Full Text] [Related]
7. [Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance].
Kiesslich R; Holfelder M; Will D; Hahn M; Nafe B; Genitsariotis R; Daniello S; Maeurer M; Jung M
Z Gastroenterol; 2001 Dec; 39(12):985-92. PubMed ID: 11753782
[TBL] [Abstract][Full Text] [Related]
8. Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction.
Leem G; Sung MJ; Park JH; Kim SJ; Jo JH; Lee HS; Ku NS; Park JY; Bang S; Park SW; Song SY; Chung MJ
Am J Gastroenterol; 2024 Jan; 119(1):183-190. PubMed ID: 37713527
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.
Mehal WZ; Culshaw KD; Tillotson GS; Chapman RW
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):841-5. PubMed ID: 8574715
[TBL] [Abstract][Full Text] [Related]
10. [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
Kiesslich R; Will D; Hahn M; Nafe B; Genitsariotis R; Mäurer M; Jung M
Z Gastroenterol; 2003 Jan; 41(1):5-10. PubMed ID: 12541165
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a meta-analysis.
Bai Y; Gao F; Gao J; Zou DW; Li ZS
Pancreas; 2009 Mar; 38(2):126-30. PubMed ID: 19238021
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Davis AJ; Kolios G; Alveyn CG; Robertson DA
Aliment Pharmacol Ther; 1998 Mar; 12(3):207-11. PubMed ID: 9570254
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antibiotic use to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis.
Ishigaki T; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishii Y; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2015; 62(138):417-24. PubMed ID: 25916074
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Post Endoscopic Retrograde Cholangiopancreatography Cholangitis.
Boonsinsukh T; Viriyaroj V; Yodying H
J Med Assoc Thai; 2016 Nov; 99 Suppl 8():S166-S170. PubMed ID: 29906028
[TBL] [Abstract][Full Text] [Related]
15. The role of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography; a retrospective single-center evaluation.
Kager LM; Sjouke B; van den Brand M; Naber TH; Ponsioen CY
Scand J Gastroenterol; 2012 Feb; 47(2):245-50. PubMed ID: 22242617
[TBL] [Abstract][Full Text] [Related]
16. Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.
Schwab D; Grauer M; Hahn EG; Mühldorfer S
Aliment Pharmacol Ther; 2005 Sep; 22(5):417-22. PubMed ID: 16128679
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration.
Sharara AI; El Hajj II; Mroueh M; Kyriacos SB; Abdul-Baki H; Chaar HF; Aoun E; Hashash JG; Mansour NM; Kanj SS
South Med J; 2011 Mar; 104(3):189-94. PubMed ID: 21297547
[TBL] [Abstract][Full Text] [Related]
18. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.
Rerknimitr R; Fogel EL; Kalayci C; Esber E; Lehman GA; Sherman S
Gastrointest Endosc; 2002 Dec; 56(6):885-9. PubMed ID: 12447303
[TBL] [Abstract][Full Text] [Related]
19. Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction.
Miyatani H; Mashima H; Sekine M; Matsumoto S
Sci Rep; 2018 Jul; 8(1):9951. PubMed ID: 29967373
[TBL] [Abstract][Full Text] [Related]
20. Effect of CO2 cholangiography on post-ERCP cholangitis in patients with unresectable malignant hilar obstruction - a prospective, randomized controlled study.
Zhang R; Zhao L; Liu Z; Wang B; Hui N; Wang X; Huang R; Luo H; Fan D; Pan Y; Guo X
Scand J Gastroenterol; 2013 Jun; 48(6):758-63. PubMed ID: 23621432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
